New comment by at University Of Utah Division Of Nephrology And Hypertension ( March 28, 2024)
Using Lumasiran preemptively to prevent the recurrence of oxalate nephropathy in patients with PH1 certainly seems like a good approach. Although I have not had the chance to ...